]K$+FI|J-K(&42+7T@^(H7{EFPT^'@}PU-/;
SYSTEM PROCESSING...
]K$+FI|J-K(&42+7T@^(H7{EFPT^'@}PU-/;
SYSTEM PROCESSING...
Posted: 2025-04-24 18:27:02 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 18:27:19 UTC
Verified By
Rollup News
A recent study indicates that lingering symptoms following Lyme disease treatment may stem from persistent fragments of the bacteria's cell wall, specifically peptidoglycan, which triggers ongoing inflammation in the liver and joints.
Persistent Lyme symptoms may be caused by lingering bacterial debris.
Unique peptidoglycan in Lyme bacteria resists breakdown, causing inflammation.
New treatments may target inflammation rather than the bacteria itself.
Borrelia burgdorferi's peptidoglycan resists breakdown.
Accumulation of peptidoglycan in liver and joints.
Ongoing inflammation despite antibiotic treatment.